glp-1 drug updates The revolution: What UAB researchers are discovering about how these drugs work Weight loss drugs don't work
Description
Although the direct inhibition of DPP-4 activity does not seem to regulate bone remodeling, the impact of DPP-4 on bone metabolism is indirect, involving the modulation of DPP-4 substrates and inflammation within the bone microenvironment
Data Extraction Approval dates were obtained from Drugs@FDA
Certain groups of people should not use Semaglutide GLP-1 or should use it with caution under healthcare professional supervision
Thats quite interesting and exciting. Another trial found weight-loss jabs could almost halve the risk of obesity-related cancers, with the effects larger than would be expected from weight loss alone
Exploring weight loss medication combinations clarifies risks and benefits
Saxenda may be the new kid on the block for obesity management but its not a new medication
